Skip to main content
Journal ArticleOPEN ACCESS

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer

  • Sadoff J
  • Davis K
  • Douoguih M
New England Journal of Medicine (2021) 384(20) 1965-1966
DOI: 10.1056/nejmc2106075
108Citations
Citations of this article
105Readers
Mendeley users who have this article in their library.

Abstract

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Manufacturer’s Response The manufacturer of the Ad26.COV2.S vaccine against Covid-19 comments on recent reports of thrombosis, including ...

Cite

CITATION STYLE

APA

Sadoff, J., Davis, K., & Douoguih, M. (2021). Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer. New England Journal of Medicine, 384(20), 1965–1966. https://doi.org/10.1056/nejmc2106075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free